Obermeier, K.T.; Frank, T.; Hildebrandt, T.; Otto, S.; Poxleitner, P.; Dewenter, I.
Osteonecrosis of the Jaw Associated with Obinutuzumab in a Patient with Preceding Follicular Non-Hodgkin’s Lymphoma. J. Pers. Med. 2025, 15, 138.
https://doi.org/10.3390/jpm15040138
AMA Style
Obermeier KT, Frank T, Hildebrandt T, Otto S, Poxleitner P, Dewenter I.
Osteonecrosis of the Jaw Associated with Obinutuzumab in a Patient with Preceding Follicular Non-Hodgkin’s Lymphoma. Journal of Personalized Medicine. 2025; 15(4):138.
https://doi.org/10.3390/jpm15040138
Chicago/Turabian Style
Obermeier, Katharina Theresa, Thomas Frank, Tim Hildebrandt, Sven Otto, Philipp Poxleitner, and Ina Dewenter.
2025. "Osteonecrosis of the Jaw Associated with Obinutuzumab in a Patient with Preceding Follicular Non-Hodgkin’s Lymphoma" Journal of Personalized Medicine 15, no. 4: 138.
https://doi.org/10.3390/jpm15040138
APA Style
Obermeier, K. T., Frank, T., Hildebrandt, T., Otto, S., Poxleitner, P., & Dewenter, I.
(2025). Osteonecrosis of the Jaw Associated with Obinutuzumab in a Patient with Preceding Follicular Non-Hodgkin’s Lymphoma. Journal of Personalized Medicine, 15(4), 138.
https://doi.org/10.3390/jpm15040138
